Back to Axiom Investors LLC Axiom Investors LLC

PTGXPTGX

7 quarters

Position history for Axiom Investors LLCAxiom Investors LLC's holdings in Protagonist Therapeutics, Inc.

Yes. Axiom Investors holds 83,951 shares of PTGX, worth $11.8M, as of its Q3 2026 13F filing. It increased the position by 2,268 shares (+2.8%) from Q2 2026. Axiom Investors has held PTGX since Q1 2025, across 7 quarterly 13F filings. PTGX is 0.1% of Axiom Investors' reported 13F portfolio.

Current Value

$11.8M

Current Shares

83,951

Total Value Change

+$9.9M

Total Shares Change

+43,982

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
83,951
+2.8%
$11.8M0.1%$140.89
29
2026-Q2
Decreased
81,683
-4.4%
$10M0.1%$122.58
0
2026-Q1
Decreased
85,475
-4.5%
$9M0.1%$105.40
0
2025-Q4
Increased
89,468
+11.7%
$7.8M0.1%$87.34
31
2025-Q3
Increased
80,113
+56.4%
$5.3M0.0%$66.43
38
2025-Q2
Increased
51,233
+28.2%
$2.8M0.0%$55.27
33
2025-Q1
New
39,969
—
$1.9M0.0%$48.36
36

Optional analytics helps us improve. How it’s used